Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-26

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for the generic drug amlodipine besylate submitted by Epic Pharma, LLC. This represents authorization of a supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)